Table 2.
Combination Analgesia Group | Ropivacaine Group | Control Group | Combination Analgesia vs Ropivacaine Group | Combination Analgesia vs Control Group | Ropivacaine Group vs Control Group | |
---|---|---|---|---|---|---|
Number | 31 | 30 | 32 | P value | ||
Primary outcome | ||||||
12 h | 3 (2,3) | 3 (3,4) | 4 (4,5) | 0.058 | <0.001 | <0.001 |
Secondary outcome | ||||||
0 h | 2 (2,2) | 2 (2,3) | 4 (3,4) | >0.9 | <0.001 | <0.001 |
2 h | 2 (2,3) | 2 (2,3) | 4 (4,4.75) | >0.9 | <0.001 | <0.001 |
24 h | 3 (2,3) | 4 (3,4) | 4 (3,5) | 0.005 | <0.001 | 0.148 |
3 d | 3 (2,3) | 3 (2,3.25) | 3.5 (3,4) | 0.117 | <0.001 | 0.025 |
5 d | 2 (2,3) | 3 (2,3) | 3 (3,3) | 0.271 | <0.001 | 0.107 |
7 d | 2 (1,2) | 2 (2,2) | 2 (2,3) | 0.193 | <0.001 | 0.091 |
14 d | 1 (1,1) | 2 (1,2) | 2 (1,2) | 0.005 | <0.001 | >0.9 |
PCA dose | 40 (28,50) | 49 (42.25,55) | 55 (40,66) | 0.06 | 0.001 | 0.765 |
Note: Data are expressed as median (lower and upper quartiles).
Abbreviation: PCA, patient-controlled analgesia.